In asthma management, which systemic corticosteroid is preferred, prednisone or prednisolone?

Prednisone and Prednisolone Are Equally Effective for Asthma Management

Both prednisone and prednisolone are considered equivalent for treating asthma exacerbations, with no clinically meaningful difference in efficacy between them. The choice between these two systemic corticosteroids should be based primarily on patient-specific factors rather than superiority of one agent over the other.

Evidence from Guidelines

The NAEPP Expert Panel Report 3 (EPR-3) lists both prednisone and prednisolone interchangeably in their treatment algorithms for asthma exacerbations, with identical dosing recommendations and no stated preference for one over the other 1, 2. This equivalence is reinforced across multiple guideline iterations, indicating that expert consensus views these agents as therapeutically interchangeable.

For acute exacerbations:

• Adults: 40-80 mg/day in 1-2 divided doses until PEF reaches 70% of predicted or personal best
• Children: 1-2 mg/kg/day (maximum 60 mg/day) in divided doses until PEF reaches 70% of predicted or personal best
• Duration: 5-10 days for outpatient "burst" therapy; 3-10 days for ED visits or hospitalizations 1, 2

The guidelines explicitly state: "There is no known advantage for higher doses of corticosteroids in severe asthma exacerbations nor is there any advantage for intravenous administration over oral therapy provided gastrointestinal transit time or absorption is not impaired" 1, 2.

Key Clinical Consideration: The Prednisone-to-Prednisolone Conversion

The critical distinction between these medications is pharmacological rather than clinical. Prednisone is a prodrug that requires hepatic conversion to prednisolone (its active form) to exert therapeutic effects 3. This conversion occurs efficiently in most patients, making the two agents clinically equivalent in the vast majority of cases.

When to Choose Prednisolone Over Prednisone:

Prednisolone should be specifically selected in patients with:

• Severe hepatic dysfunction or cirrhosis (impaired conversion of prednisone to active prednisolone)
• Infants and very young children (less mature hepatic enzyme systems)
• Patients taking medications that induce hepatic metabolism (rifampin, phenytoin, carbamazepine, phenobarbital) 3
• Patients with documented poor response to prednisone who may have incomplete conversion 3

The FDA labeling confirms prednisolone is indicated for asthma management with the same dosing parameters as prednisone 4.

Practical Dosing Considerations

For children with acute asthma exacerbations:

• Research supports that 1 mg/kg/day prednisolone is non-inferior to 2 mg/kg/day for moderate exacerbations, with significantly less vomiting at the lower dose 5
• The dose of 0.5 mg/kg/day has also been shown effective in hospitalized children, with no advantage to higher doses 6
• Recommendation: Start with 1-2 mg/kg/day (maximum 60 mg/day) as per guidelines, but recognize that lower doses may be sufficient for moderate exacerbations 1, 5

Duration of therapy:

• 5-day courses are as effective as 10-day courses when patients are maintained on inhaled corticosteroids 7
• No need to taper for courses <1 week, and probably unnecessary even for 10-day courses if patients are on inhaled corticosteroids 1, 2

Important Caveats

Avoid chronic or repeated oral corticosteroid use whenever possible. Even low cumulative exposures (≤500 mg prednisolone-equivalent) are associated with increased risks of fractures, adrenal insufficiency, depression/anxiety, and increased mortality 8. This underscores the importance of optimizing controller therapy with inhaled corticosteroids and other long-term control medications to minimize systemic corticosteroid requirements.

The British Thoracic Society guidelines recommend prednisolone 30-60 mg daily for acute severe asthma, with continuation until symptoms stabilize 9, consistent with the NAEPP recommendations.

Bottom Line Algorithm

1. For most patients: Either prednisone or prednisolone is appropriate—choose based on availability and cost
2. For patients with liver disease, very young children, or those on enzyme-inducing drugs: Choose prednisolone specifically
3. Dose: Adults 40-80 mg/day; Children 1-2 mg/kg/day (max 60 mg/day)
4. Duration: 5-10 days; no taper needed for short courses
5. Always ensure: Patient is on or started on inhaled corticosteroids concurrently 1, 2